EuropaWire12m
Novartis Acquires Anthos Therapeutics to Advance Abelacimab in Stroke and Thrombosis Prevention
Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...
Early diagnosis, advancements in treating atrial fibrillation lead to better outcomes
A rapid heartbeat and shortness of breath could be signs of atrial fibrillation (AFib), an irregular heartbeat. Dr. Jim Stone, a cardiac electrophysiologist at North Medical Center in Tupelo, helps ...
AMBCrypto20h
VEE crypto soars 100% in 7 days – Can it sustain the rally?
VEE crypto, the native token of the SmartNFT analytics platform BLOCKv, soared by 100% in 7 days. In doing so, it ...
emjreviews.com21h
Unveiling the Overlap: Cardiac Sarcoidosis and Arrhythmogenic Cardiomyopathy
Cardiac sarcoidosis and ACM genetic variants coexist with distinct features, highlighting the need for refined clinical ...
Novartis1d
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
TMCnet1d
Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion
Anthos is currently conducting a phase 3 clinical study in patients with atrial fibrillation with high risk for stroke or systemic embolism (LILAC-TIMI 76) as well as two phase 3 studies in patients ...
AI proves better than humans at analyzing long-term ECG recordings in large international study
In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may ...
Motor Authority15d
Ken Block's Hoonitruck sold at auction for $990,000
Ken Block's "Hoonitruck," a heavily modified 1977 Ford F-150 used in the late rally driver and viral-video star's "Gymkhana" series, was up for grabs at Barrett-Jackson's annual Scottsdale ...
The New England Journal of Medicine21d
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation ... in patients with atrial fibrillation is unknown. Patients with atrial ...
Business Wire22d
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound ...
BBC25d
Over 100 London tower blocks may have safety issues
Thousands of people in London could be living in high-rise tower blocks with known safety issues, a BBC London investigation has found. More than 100 high-rise residential buildings across the ...
verywellhealth25d
Atrial Fibrillation Life Expectancy
Atrial fibrillation (AFib) can affect life expectancy due to factors that include age, underlying health conditions, race, and how this common cardiac arrhythmia—or abnormal heart rhythm— is treated.